2016 年的期刊文章 · 第 12 页

共 1345 篇,按发表时间排,新的在前,每页 40 篇。这一页是 2016-07-26 到 2016-07-11。

按期刊、按主题看 →

第 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 页

SiM Other · 发表于 2016-07-26

Prevalence odds ratio versus prevalence ratio: choice comes with consequences

Ashutosh R. Tamhane, Andrew O. Westfall, Greer A. Burkholder, Gary R. Cutter

摘要

Odds ratio, risk ratio, and prevalence ratio are some of the measures of association which are often reported in research studies quantifying the relationship between an independent variable and the outcome of interest. There has been much debate on the issue of which measure is appropriate to report depending on the study design. However, the literature on selecting a particular category of the outcome to be modeled and/or change in reference group for categorical independent variables and the effect on statistical significance, although known, is scantly discussed nor published with examples. In this article, we provide an example of a cross-sectional study wherein prevalence ratio was chosen over (Prevalence) odds ratio and demonstrate the analytic implications of the choice of category to be modeled and choice of reference level for independent variables. Copyright © 2016 John Wiley & Sons, Ltd. *(abstract via PubMed)*

SMMR Longitudinal Data Bayesian Methods Survival Analysis · 发表于 2016-07-26

Joint modeling of longitudinal zero-inflated count and time-to-event data: A Bayesian perspective

Huirong Zhu, Stacia M DeSantis, Sheng Luo

摘要

Longitudinal zero-inflated count data are encountered frequently in substance-use research when assessing the effects of covariates and risk factors on outcomes. Often, both the time to a terminal event such as death or dropout and repeated measure count responses are collected for each subject. In this setting, the longitudinal counts are censored by the terminal event, and the time to the terminal event may depend on the longitudinal outcomes. In the study described herein, we expand the class of joint models for longitudinal and survival data to accommodate zero-inflated counts and time-to-event data by using a Cox proportional hazards model with piecewise constant baseline hazard. We use a Bayesian framework via Markov chain Monte Carlo simulations implemented in the BUGS programming language. Via an extensive simulation study, we apply the joint model and obtain estimates that are more accurate than those of the corresponding independence model. We apply the proposed method to an alpha-tocopherol, beta-carotene lung cancer prevention study.

Biometrics Causal Inference Longitudinal Data · 发表于 2016-07-26

Dynamic Models for Estimating the Effect of HAART on CD4 in Observational Studies: Application to the Aquitaine Cohort and the Swiss HIV Cohort Study

Mélanie Prague, Daniel Commenges, Jon Michael Gran, Bruno Ledergerber, Jim Young, Hansjakob Furrer, Rodolphe Thiébaut

摘要

Summary: Highly active antiretroviral therapy (HAART) has proved efficient in increasing CD4 counts in many randomized clinical trials. Because randomized trials have some limitations (e.g., short duration, highly selected subjects), it is interesting to assess the effect of treatments using observational studies. This is challenging because treatment is started preferentially in subjects with severe conditions. This general problem had been treated using Marginal Structural Models (MSM) relying on the counterfactual formulation. Another approach to causality is based on dynamical models. We present three discrete-time dynamic models based on linear increments models (LIM): the first one based on one difference equation for CD4 counts, the second with an equilibrium point, and the third based on a system of two difference equations, which allows jointly modeling CD4 counts and viral load. We also consider continuous-time models based on ordinary differential equations with non-linear mixed effects (ODE-NLME). These mechanistic models allow incorporating biological knowledge when available, which leads to increased statistical evidence for detecting treatment effect. Because inference in ODE-NLME is numerically challenging and requires specific methods and softwares, LIM are a valuable intermediary option in terms of consistency, precision, and complexity. We compare the different approaches in simulation and in illustration on the ANRS CO3 Aquitaine Cohort and the Swiss HIV Cohort Study.

JRSSB Other · 发表于 2016-07-26

Continuous Auto-Regressive Moving Average Random Fields on Rn

Peter J. Brockwell, Yasumasa Matsuda

摘要

Summary: We define an isotropic Lévy-driven continuous auto-regressive moving average CARMA(p, q) random field on Rn as the integral of a radial CARMA kernel with respect to a Lévy sheet. Such fields constitute a parametric family characterized by an auto-regressive polynomial a and a moving average polynomial b having zeros in both the left and the right complex half-planes. They extend the well-balanced Ornstein–Uhlenbeck process of Schnurr and Woerner to a well-balanced CARMA process in one dimension (with a much richer class of autocovariance functions) and to an isotropic CARMA random field on Rn for n > 1. We derive second-order properties of these random fields and extend the results to a larger class of anisotropic CARMA random fields. If the driving Lévy sheet is compound Poisson it is trivial to simulate the corresponding random field on any bounded subset of Rn. A method for joint estimation of the CARMA kernel parameters and knot locations is proposed for compound-Poisson-driven fields and is illustrated by applications to simulated data and Tokyo land price data.

SMMR Diagnostics & Prediction · 发表于 2016-07-26

A review of statistical updating methods for clinical prediction models

Ting-Li Su, Thomas Jaki, Graeme L Hickey, Iain Buchan, Matthew Sperrin

摘要

A clinical prediction model is a tool for predicting healthcare outcomes, usually within a specific population and context. A common approach is to develop a new clinical prediction model for each population and context; however, this wastes potentially useful historical information. A better approach is to update or incorporate the existing clinical prediction models already developed for use in similar contexts or populations. In addition, clinical prediction models commonly become miscalibrated over time, and need replacing or updating. In this article, we review a range of approaches for re-using and updating clinical prediction models; these fall in into three main categories: simple coefficient updating, combining multiple previous clinical prediction models in a meta-model and dynamic updating of models. We evaluated the performance (discrimination and calibration) of the different strategies using data on mortality following cardiac surgery in the United Kingdom: We found that no single strategy performed sufficiently well to be used to the exclusion of the others. In conclusion, useful tools exist for updating existing clinical prediction models to a new population or context, and these should be implemented rather than developing a new clinical prediction model from scratch, using a breadth of complementary statistical methods.

Biometrika Clinical Trials · 发表于 2016-07-25

On the win-ratio statistic in clinical trials with multiple types of event

D. Oakes

摘要

Pocock et al. (2012), following Finkelstein & Schoenfeld (1999), has popularized the win ratio for analysis of controlled clinical trials with multiple types of outcome event. The approach uses pairwise comparisons between patients in the treatment and control groups using a primary outcome, say the time to death, with ties broken using a secondary outcome, say the time to hospitalization. In general the observed pairwise preferences and the weight they attach to the component rankings will depend on the distribution of potential follow-up time. We present expressions for the win and loss probabilities for general bivariate survival models when follow-up of all patients is limited to a specified time horizon. In the special case of a bivariate Lehmann model we show that the win ratio does not depend on this horizon. We show how the win ratio may be estimated nonparametrically or from a parametric model. Extensions to events of three or more types are described. Application of the method of marginal estimation due to Wei et al. (1989) to this problem is described. *(abstract via OpenAlex)*

Biometrika Causal Inference · 发表于 2016-07-25

A goodness-of-fit test for structural nested mean models

S. Yang, J. J. Lok

摘要

Coarse structural nested mean models are tools to estimate treatment effects from longitudinal observational data with time-dependent confounding. There is, however, no guidance on how to specify the treatment effect model, and model misspecification can lead to bias. We derive a goodness-of-fit test based on modified overidentification restrictions tests for evaluating a treatment effect model, and show that our test statistic is doubly-robust in the sense that, with a correct treatment effect model, the test has the correct type-I error if either the treatment initiation model or a nuisance regression outcome model is correctly specified. In a simulation study we show that the test has correct type-I error and can detect model misspecification. We use the test to study how the timing of antiretroviral treatment initiation after HIV infection predicts the effect of one year of treatment in HIV-positive patients with acute and early infection. *(abstract via PubMed)*

SiM Bayesian Methods · 发表于 2016-07-24

Integrating independent spatio‐temporal replications to assess population trends in disease spread

John VanBuren, Jacob J. Oleson, Gideon K. D. Zamba, Michael Wall

摘要

Glaucoma is the second leading cause of blindness in the USA. A visual field test (perimetry) is used to sample and quantitate visual field function in preselected regions in the eye. These regions can be considered a spatial field with replications across independently measured individuals. At return visits, a new set of visual field measurements is obtained producing a subject specific spatio‐temporal dataset. We develop a Bayesian hierarchical modeling framework to analyze these spatio‐temporal datasets both for individual level spread and as aggregate population level trends. Our model extends previous research utilizing a dimension reduction matrix and individual specific latent variables. Human characteristics are incorporated into the model to help explain glaucoma progression. One beneficial product of our model is smoothed estimates for individuals. We also specify how progression rates are computed for monitoring purposes so that clinicians can track changes and predict forward in time. Copyright © 2016 John Wiley & Sons, Ltd.

SiM Other · 发表于 2016-07-24

Identifying cost‐effective dynamic policies to control epidemics

Reza Yaesoubi, Ted Cohen

摘要

We describe a mathematical decision model for identifying dynamic health policies for controlling epidemics. These dynamic policies aim to select the best current intervention based on accumulating epidemic data and the availability of resources at each decision point. We propose an algorithm to approximate dynamic policies that optimize the population's net health benefit, a performance measure which accounts for both health and monetary outcomes. We further illustrate how dynamic policies can be defined and optimized for the control of a novel viral pathogen, where a policy maker must decide (i) when to employ or lift a transmission‐reducing intervention (e.g. school closure) and (ii) how to prioritize population members for vaccination when a limited quantity of vaccines first become available. Within the context of this application, we demonstrate that dynamic policies can produce higher net health benefit than more commonly described static policies that specify a pre‐determined sequence of interventions to employ throughout epidemics. Copyright © 2016 John Wiley & Sons, Ltd.

SiM Survival Analysis · 发表于 2016-07-24

Estimating overall exposure effects for the clustered and censored outcome using random effect Tobit regression models

Wei Wang, Michael E. Griswold

摘要

The random effect Tobit model is a regression model that accommodates both left‐ and/or right‐censoring and within‐cluster dependence of the outcome variable. Regression coefficients of random effect Tobit models have conditional interpretations on a constructed latent dependent variable and do not provide inference of overall exposure effects on the original outcome scale. Marginalized random effects model (MREM) permits likelihood‐based estimation of marginal mean parameters for the clustered data. For random effect Tobit models, we extend the MREM to marginalize over both the random effects and the normal space and boundary components of the censored response to estimate overall exposure effects at population level. We also extend the ‘Average Predicted Value’ method to estimate the model‐predicted marginal means for each person under different exposure status in a designated reference group by integrating over the random effects and then use the calculated difference to assess the overall exposure effect. The maximum likelihood estimation is proposed utilizing a quasi‐Newton optimization algorithm with Gauss–Hermite quadrature to approximate the integration of the random effects. We use these methods to carefully analyze two real datasets. Copyright © 2016 John Wiley & Sons, Ltd.

SiM Other · 发表于 2016-07-21

Using semi‐Markov processes to study timeliness and tests used in the diagnostic evaluation of suspected breast cancer

R. A. Hubbard, J. Lange, Y. Zhang, B. A. Salim, J. R. Stroud, L. Y. T. Inoue

摘要

Diagnostic evaluation of suspected breast cancer due to abnormal screening mammography results is common, creates anxiety for women and is costly for the healthcare system. Timely evaluation with minimal use of additional diagnostic testing is key to minimizing anxiety and cost. In this paper, we propose a Bayesian semi‐Markov model that allows for flexible, semi‐parametric specification of the sojourn time distributions and apply our model to an investigation of the process of diagnostic evaluation with mammography, ultrasound and biopsy following an abnormal screening mammogram. We also investigate risk factors associated with the sojourn time between diagnostic tests. By utilizing semi‐Markov processes, we expand on prior work that described the timing of the first test received by providing additional information such as the mean time to resolution and proportion of women with unresolved mammograms after 90 days for women requiring different sequences of tests in order to reach a definitive diagnosis. Overall, we found that older women were more likely to have unresolved positive mammograms after 90 days. Differences in the timing of imaging evaluation and biopsy were generally on the order of days and thus did not represent clinically important differences in diagnostic delay. Copyright © 2016 John Wiley & Sons, Ltd.

SiM Survival Analysis Missing Data & Measurement Error · 发表于 2016-07-21

Multiple imputation of missing covariates for the Cox proportional hazards cure model

Lauren J. Beesley, Jonathan W. Bartlett, Gregory T. Wolf, Jeremy M. G. Taylor

摘要

We explore several approaches for imputing partially observed covariates when the outcome of interest is a censored event time and when there is an underlying subset of the population that will never experience the event of interest. We call these subjects 'cured', and we consider the case where the data are modeled using a Cox proportional hazards (CPH) mixture cure model. We study covariate imputation approaches using fully conditional specification. We derive the exact conditional distribution and suggest a sampling scheme for imputing partially observed covariates in the CPH cure model setting. We also propose several approximations to the exact distribution that are simpler and more convenient to use for imputation. A simulation study demonstrates that the proposed imputation approaches outperform existing imputation approaches for survival data without a cure fraction in terms of bias in estimating CPH cure model parameters. We apply our multiple imputation techniques to a study of patients with head and neck cancer. Copyright © 2016 John Wiley & Sons, Ltd. *(abstract via PubMed)*

Biometrika Longitudinal Data Missing Data & Measurement Error · 发表于 2016-07-21

Intrinsic efficiency and multiple robustness in longitudinal studies with drop-out: Table 1

Peisong Han

摘要

Intrinsic efficiency and multiple robustness are desirable properties in missing data analysis. We establish both for estimating the mean of a response at the end of a longitudinal study with drop-out. The idea is to calibrate the estimated missingness probability at each visit using data from past visits. We consider one working model for the missingness probability and multiple working models for the data distribution. Intrinsic efficiency guarantees that, when the missingness probability is correctly modelled, the multiple data distribution models, combined with data prior to the end of the study, are optimally accommodated to maximize efficiency. The efficiency generally increases with the number of data distribution models, except where one such model is correctly specified as well, in which case all the proposed estimators attain the semiparametric efficiency bound. Multiple robustness ensures estimation consistency if the missingness probability model is misspecified but one data distribution model is correct. Our proposed estimators are all convex combinations of the observed responses, and thus always fall within the parameter space. *(abstract via OpenAlex)*

SiM Causal Inference · 发表于 2016-07-21

Evaluation of subset matching methods and forms of covariate balance

María de los Angeles Resa, José R. Zubizarreta

摘要

This paper conducts a Monte Carlo simulation study to evaluate the performance of multivariate matching methods that select a subset of treatment and control observations. The matching methods studied are the widely used nearest neighbor matching with propensity score calipers and the more recently proposed methods, optimal matching of an optimally chosen subset and optimal cardinality matching. The main findings are: (i) covariate balance, as measured by differences in means, variance ratios, Kolmogorov–Smirnov distances, and cross‐match test statistics, is better with cardinality matching because by construction it satisfies balance requirements; (ii) for given levels of covariate balance, the matched samples are larger with cardinality matching than with the other methods; (iii) in terms of covariate distances, optimal subset matching performs best; (iv) treatment effect estimates from cardinality matching have lower root‐mean‐square errors, provided strong requirements for balance, specifically, fine balance, or strength‐kbalance, plus close mean balance. In standard practice, a matched sample is considered to be balanced if the absolute differences in means of the covariates across treatment groups are smaller than 0.1 standard deviations. However, the simulation results suggest that stronger forms of balance should be pursued in order to remove systematic biases due to observed covariates when a difference in means treatment effect estimator is used. In particular, if the true outcome model is additive, then marginal distributions should be balanced, and if the true outcome model is additive with interactions, then low‐dimensional joints should be balanced. Copyright © 2016 John Wiley & Sons, Ltd.

SiM Survival Analysis Nonparametric & Semiparametric · 发表于 2016-07-21

Bias and variance reduction in nonparametric estimation of time‐dependent accuracy measures

Chin‐Tsang Chiang, Ming‐Yueh Huang, Shao‐Hsuan Wang

摘要

A new nonparametric approach is developed to estimate the time‐dependent accuracy measure curves, which are defined on the cumulative cases and dynamic controls, for censored survival data. Based on an estimable survival process, the main intention of this study is to reduce the finite‐sample biases of nearest neighbor estimators. The asymptotic variances of some retrospective accuracy measure estimators are further reduced by applying a smoothing technique to the underlying process of a marker. Meanwhile, practically feasible and theoretically valid procedures are proposed for bandwidth selection in the presented estimators. In addition, the proposed methodology can be reasonably extended to accommodate stratified survival data and survival data with multiple markers. As shown in the simulations, our new estimators outperform the nearest neighbor and inverse censoring weighted estimators. Data from the AIDS Clinical Trials Group study 175 and an angiographic coronary artery disease study are also used to illustrate the proposed methodology. Copyright © 2016 John Wiley & Sons, Ltd.

Biometrika Causal Inference Bayesian Methods · 发表于 2016-07-21

A Bayesian view of doubly robust causal inference: Table 1

O. Saarela, L. R. Belzile, D. A. Stephens

摘要

In causal inference the effect of confounding may be controlled using regression adjustment in an outcome model, propensity score adjustment, inverse probability of treatment weighting or a combination of these. Approaches based on modelling the treatment assignment mechanism, along with their doubly robust extensions, have been difficult to motivate using formal likelihood-based or Bayesian arguments, as the treatment assignment model plays no part in inferences concerning the expected outcomes. On the other hand, forcing dependency between the outcome and treatment assignment models by allowing the former to be misspecified results in loss of the balancing property of the propensity scores and the loss of any double robustness. In this paper, we explain in the framework of misspecified models why doubly robust inferences cannot arise from purely likelihood-based arguments. As an alternative to Bayesian propensity score analysis, we propose a Bayesian posterior predictive method for constructing doubly robust estimation procedures by incorporating the inverse treatment assignment probabilities as importance sampling weights in Monte Carlo integration. *(abstract via OpenAlex)*

SMMR Clinical Trials · 发表于 2016-07-20

Two-stage seamless transition design from open-label single-arm to randomized double-arm clinical trials

Haolun Shi, Guosheng Yin

摘要

Conventional phase II clinical trials use either a single- or multi-arm comparison scheme to examine the therapeutic effects of the experimental drug. Both single- and multi-arm evaluations have their own merits; for example, single-arm phase II trials are easy to conduct and often require a smaller sample size, while multiarm trials are randomized and typically lead to a more objective comparison. To bridge the single- and double-arm schemes in one trial, we propose a two-stage design, in which the first stage takes a single-arm comparison of the experimental drug with the standard response rate (no concurrent treatment) and the second stage imposes a two-arm comparison by adding an active control arm. The design is calibrated using a new concept, the detectable treatment difference, to balance the trade-offs between futility termination, power, and sample size. We conduct extensive simulation studies to examine the operating characteristics of the proposed method and provide an illustrative example of our design.

SMMR Bayesian Methods Spatial & Time Series · 发表于 2016-07-20

Spatially-dependent Bayesian model selection for disease mapping

Rachel Carroll, Andrew B Lawson, Christel Faes, Russell S Kirby, Mehreteab Aregay, Kevin Watjou

摘要

In disease mapping where predictor effects are to be modeled, it is often the case that sets of predictors are fixed, and the aim is to choose between fixed model sets. Model selection methods, both Bayesian model selection and Bayesian model averaging, are approaches within the Bayesian paradigm for achieving this aim. In the spatial context, model selection could have a spatial component in the sense that some models may be more appropriate for certain areas of a study region than others. In this work, we examine the use of spatially referenced Bayesian model averaging and Bayesian model selection via a large-scale simulation study accompanied by a small-scale case study. Our results suggest that BMS performs well when a strong regression signature is found.

SMMR Survival Analysis · 发表于 2016-07-20

Simple linear regression with interval censored dependent and independent variables

Marcel F de Lima Taga, Julio M Singer

摘要

We consider a simple linear regression model that accommodates situations where both the dependent and the independent variables are interval censored. We obtain maximum likelihood estimators of its parameters and compare their performance with that of estimators derived under ordinary linear regression models. We also develop prediction intervals for the response and illustrate the results with data from an audiometric study designed to evaluate the possibility of prediction of behavioural thresholds from physiological thresholds.

Biometrics Latent Variables & Mixtures · 发表于 2016-07-20

Ordinal Probability Effect Measures for Group Comparisons in Multinomial Cumulative Link Models

Alan Agresti, Maria Kateri

摘要

Summary: We consider simple ordinal model-based probability effect measures for comparing distributions of two groups, adjusted for explanatory variables. An “ordinal superiority” measure summarizes the probability that an observation from one distribution falls above an independent observation from the other distribution, adjusted for explanatory variables in a model. The measure applies directly to normal linear models and to a normal latent variable model for ordinal response variables. It equals for the corresponding ordinal model that applies a probit link function to cumulative multinomial probabilities, for standard normal cdf and effect that is the coefficient of the group indicator variable. For the more general latent variable model for ordinal responses that corresponds to a linear model with other possible error distributions and corresponding link functions for cumulative multinomial probabilities, the ordinal superiority measure equals with the log–log link and equals approximately with the logit link, where is the group effect. Another ordinal superiority measure generalizes the difference of proportions from binary to ordinal responses. We also present related measures directly for ordinal models for the observed response that need not assume corresponding latent response models. We present confidence intervals for the measures and illustrate with an example.

Biometrics Longitudinal Data Survival Analysis · 发表于 2016-07-20

On Longitudinal Prediction with Time-to-Event Outcome: Comparison of Modeling Options

Marlena Maziarz, Patrick Heagerty, Tianxi Cai, Yingye Zheng

摘要

Summary: Long-term follow-up is common in many medical investigations where the interest lies in predicting patients’ risks for a future adverse outcome using repeatedly measured predictors over time. A key quantity is the likelihood of developing an adverse outcome among individuals who survived up to time s given their covariate information up to time s. Simple, yet reliable, methodology for updating the predicted risk of disease progression using longitudinal markers remains elusive. Two main approaches have been considered in the literature. One approach, based on joint modeling (JM) of failure time and longitudinal covariate process (Tsiatis and Davidian, 2004), derives such longitudinal predictive probability from the joint probability of a longitudinal marker and an event at a given time. A second approach, the partly conditional (PC) modeling (Zheng and Heagerty, 2005), directly models the predictive probability conditional on survival up to a landmark time and information accrued by that time. In this article, we propose new PC models for longitudinal prediction that are more flexible than joint modeling and improve the prediction accuracy over existing PC models. We provide procedures for making inference regarding future risk for an individual with longitudinal measures up to a given time. In addition, we conduct simulations to evaluate both JM and PC approaches in order to provide practical guidance on modeling choices. We use standard measures of predictive accuracy adapted to our setting to explore the predictiveness of the two approaches. We illustrate the performance of the two approaches on a dataset from the End Stage Renal Disease Study (ESRDS).

SMMR Survey & Sampling Econometrics & Economics · 发表于 2016-07-20

Modeling excess zeros and heterogeneity in count data from a complex survey design with application to the demographic health survey in sub-Saharan Africa

Lin Dai, Michael D Sweat, Mulugeta Gebregziabher

摘要

Purpose: To show a novel application of a weighted zero-inflated negative binomial model in modeling count data with excess zeros and heterogeneity to quantify the regional variation in HIV-AIDS prevalence in sub-Saharan African countries. Methods: Data come from latest round of the Demographic and Health Survey (DHS) conducted in three countries (Ethiopia-2011, Kenya-2009 and Rwanda-2010) using a two-stage cluster sampling design. The outcome is an aggregate count of HIV cases in each census enumeration area of each country. The outcome data are characterized by excess zeros and heterogeneity due to clustering. We compare scale weighted zero-inflated negative binomial models with and without random effects to account for zero-inflation, complex survey design and clustering. Finally, we provide marginalized rate ratio estimates from the best zero-inflated negative binomial model. Results: The best fitting zero-inflated negative binomial model is scale weighted and with a common random intercept for the three countries. Rate ratio estimates from the final model show that HIV prevalence is associated with age and gender distribution, HIV acceptance, HIV knowledge, and its regional variation is associated with divorce rate, burden of sexually transmitted diseases and rural residence. Conclusions: Scale weighted zero-inflated negative binomial with proper modeling of random effects is shown to be the best model for count data from a complex survey design characterized by excess zeros and extra heterogeneity. In our data example, the final rate ratio estimates show significant regional variation in the factors associated with HIV prevalence indicating that HIV intervention strategies should be tailored to the unique factors found in each country.

SMMR Survival Analysis Latent Variables & Mixtures · 发表于 2016-07-20

Between-within effects in survival models with cross-classified clustering: Application to the evaluation of the effectiveness of medical devices

Guy Cafri, Juanjuan Fan

摘要

In many medical applications involving observational survival data there will be a cross-classification of doctors and hospitals, as well as an interest in controlling for potentially confounding doctor and hospital effects when evaluating the effectiveness of a medical intervention. In this paper, we propose the use of a between-within model with cross-classified random effects and show through simulation that it performs better than alternative models. A real data example illustrates the application of the proposed model in a study of the survival of hip implants. The proposed model has broad utility in determining the effectiveness of medical interventions.

SMMR Survival Analysis Bayesian Methods High-Dimensional · 发表于 2016-07-20

Bayesian variable selection in the accelerated failure time model with an application to the surveillance, epidemiology, and end results breast cancer data

Zhen Zhang, Samiran Sinha, Tapabrata Maiti, Eva Shipp

摘要

Accelerated failure time model is a popular model to analyze censored time-to-event data. Analysis of this model without assuming any parametric distribution for the model error is challenging, and the model complexity is enhanced in the presence of large number of covariates. We developed a nonparametric Bayesian method for regularized estimation of the regression parameters in a flexible accelerated failure time model. The novelties of our method lie in modeling the error distribution of the accelerated failure time nonparametrically, modeling the variance as a function of the mean, and adopting a variable selection technique in modeling the mean. The proposed method allowed for identifying a set of important regression parameters, estimating survival probabilities, and constructing credible intervals of the survival probabilities. We evaluated operating characteristics of the proposed method via simulation studies. Finally, we apply our new comprehensive method to analyze the motivating breast cancer data from the Surveillance, Epidemiology, and End Results Program, and estimate the five-year survival probabilities for women included in the Surveillance, Epidemiology, and End Results database who were diagnosed with breast cancer between 1990 and 2000.

SMMR Other · 发表于 2016-07-20

Automated linkage of patient records from disparate sources

Xiaochun Li, Huiping Xu, Changyu Shen, Shaun Grannis

摘要

We introduce an automated method of record linkage that has two key features, automated selection of match field interactions to include in the model for estimation and automated threshold determination for classifying record pairs to matches or non-matches. We applied our method to two real-world examples. The first example demonstrated results consistent with our earlier work: When data quality is adequate and the match field discriminating power is high, matching algorithms exhibit similar performance. The second example demonstrated that our method yields a lower false positive rate and higher positive predictive value than the Fellegi-Sunter model in the face of low data quality. When compared to the Fellegi-Sunter model, simulation studies suggest that our method exhibits better overall performance as indicated by higher area under the curve, and less biased estimates for both the match prevalence rate and the m- and u-probabilities over a range of data scenarios, especially when the match prevalence is extreme. Computationally, our method is as efficient as the Fellegi-Sunter model. We recommend this method in situations that an unsupervised linking algorithm is needed.

SiM Genetics & Omics · 发表于 2016-07-20

A weighted U statistic for association analyses considering genetic heterogeneity

Changshuai Wei, Robert C. Elston, Qing Lu

摘要

Converging evidence suggests that common complex diseases with the same or similar clinical manifestations could have different underlying genetic etiologies. While current research interests have shifted toward uncovering rare variants and structural variations predisposing to human diseases, the impact of heterogeneity in genetic studies of complex diseases has been largely overlooked. Most of the existing statistical methods assume the disease under investigation has a homogeneous genetic effect and could, therefore, have low power if the disease undergoes heterogeneous pathophysiological and etiological processes. In this paper, we propose a heterogeneity‐weighted U (HWU) method for association analyses considering genetic heterogeneity. HWU can be applied to various types of phenotypes (e.g., binary and continuous) and is computationally efficient for high‐dimensional genetic data. Through simulations, we showed the advantage of HWU when the underlying genetic etiology of a disease was heterogeneous, as well as the robustness of HWU against different model assumptions (e.g., phenotype distributions). Using HWU, we conducted a genome‐wide analysis of nicotine dependence from the Study of Addiction: Genetics and Environments dataset. The genome‐wide analysis of nearly one million genetic markers took 7h, identifying heterogeneous effects of two new genes (i.e., CYP3A5 and IKBKB) on nicotine dependence. Copyright © 2016 John Wiley & Sons, Ltd.

SiM Clinical Trials · 发表于 2016-07-19

Performance of toxicity probability interval based designs in contrast to the continual reassessment method

Bethany Jablonski Horton, Nolan A. Wages, Mark R. Conaway

摘要

Toxicity probability interval designs have received increasing attention as a dose‐finding method in recent years. In this study, we compared the two‐stage, likelihood‐based continual reassessment method (CRM), modified toxicity probability interval (mTPI), and the Bayesian optimal interval design (BOIN) in order to evaluate each method's performance in dose selection for phase I trials. We use several summary measures to compare the performance of these methods, including percentage of correct selection (PCS) of the true maximum tolerable dose (MTD), allocation of patients to doses at and around the true MTD, and an accuracy index. This index is an efficiency measure that describes the entire distribution of MTD selection and patient allocation by taking into account the distance between the true probability of toxicity at each dose level and the target toxicity rate. The simulation study considered a broad range of toxicity curves and various sample sizes. When considering PCS, we found that CRM outperformed the two competing methods in most scenarios, followed by BOIN, then mTPI. We observed a similar trend when considering the accuracy index for dose allocation, where CRM most often outperformed both mTPI and BOIN. These trends were more pronounced with increasing number of dose levels. Copyright © 2016 John Wiley & Sons, Ltd.

SiM Clinical Trials · 发表于 2016-07-19

Estimands in clinical trials – broadening the perspective

Mouna Akacha, Frank Bretz, Stephen Ruberg

摘要

Defining the scientific questions of interest in a clinical trial is crucial to align its planning, design, conduct, analysis, and interpretation. However, practical experience shows that oftentimes specific choices in the statistical analysis blur the scientific question either in part or even completely, resulting in misalignment between trial objectives, conduct, analysis, and confusion in interpretation. The need for more clarity was highlighted by the Steering Committee of the International Council for Harmonization (ICH) in 2014, which endorsed a Concept Paper with the goal of developing a new regulatory guidance, suggested to be an addendum to ICH guideline E9. Triggered by these developments, we elaborate in this paper what the relevant questions in drug development are and how they fit with the current practice of intention‐to‐treat analyses. To this end, we consider the perspectives of patients, physicians, regulators, and payers. We argue that despite the different backgrounds and motivations of the various stakeholders, they all have similar interests in what the clinical trial estimands should be. Broadly, these can be classified into estimands addressing (a) lack of adherence to treatment due to different reasons and (b) efficacy and safety profiles when patients, in fact, are able to adhere to the treatment for its intended duration. We conclude that disentangling adherence to treatment and the efficacy and safety of treatment in patients that adhere leads to a transparent and clinical meaningful assessment of treatment risks and benefits. We touch upon statistical considerations and offer a discussion of additional implications. Copyright © 2016 John Wiley & Sons, Ltd.

SiM Other · 发表于 2016-07-19

Adaptive pre‐specification in randomized trials with and without pair‐matching

Laura B. Balzer, Mark J. van der Laan, Maya L. Petersen, the SEARCH Collaboration

摘要

In randomized trials, adjustment for measured covariates during the analysis can reduce variance and increase power. To avoid misleading inference, the analysis plan must be pre‐specified. However, it is often unclear a priori which baseline covariates (if any) should be adjusted for in the analysis. Consider, for example, the Sustainable East Africa Research in Community Health (SEARCH) trial for HIV prevention and treatment. There are 16 matched pairs of communities and many potential adjustment variables, including region, HIV prevalence, male circumcision coverage, and measures of community‐level viral load. In this paper, we propose a rigorous procedure to data‐adaptively select the adjustment set, which maximizes the efficiency of the analysis. Specifically, we use cross‐validation to select from a pre‐specified library the candidate targeted maximum likelihood estimator (TMLE) that minimizes the estimated variance. For further gains in precision, we also propose a collaborative procedure for estimating the known exposure mechanism. Our small sample simulations demonstrate the promise of the methodology to maximize study power, while maintaining nominal confidence interval coverage. We show how our procedure can be tailored to the scientific question (intervention effect for the study sample vs. for the target population) and study design (pair‐matched or not). Copyright © 2016 John Wiley & Sons, Ltd.

SiM Causal Inference · 发表于 2016-07-18

Optimally combining propensity score subclasses

Kara E. Rudolph, K. Ellicott Colson, Elizabeth A. Stuart, Jennifer Ahern

摘要

Propensity score methods, such as subclassification, are a common approach to control for confounding when estimating causal effects in non‐randomized studies. Propensity score subclassification groups individuals into subclasses based on their propensity score values. Effect estimates are obtained within each subclass and then combined by weighting by the proportion of observations in each subclass. Combining subclass‐specific estimates by weighting by the inverse variance is a promising alternative approach; a similar strategy is used in meta‐analysis for its efficiency. We use simulation to compare performance of each of the two methods while varying (i) the number of subclasses, (ii) extent of propensity score overlap between the treatment and control groups (i.e., positivity), (iii) incorporation of survey weighting, and (iv) presence of heterogeneous treatment effects across subclasses. Both methods perform well in the absence of positivity violations and with a constant treatment effect with weighting by the inverse variance performing slightly better. Weighting by the proportion in subclass performs better in the presence of heterogeneous treatment effects across subclasses. We apply these methods to an illustrative example estimating the effect of living in a disadvantaged neighborhood on risk of past‐year anxiety and depressive disorders among U.S. urban adolescents. This example entails practical positivity violations but no evidence of treatment effect heterogeneity. In this case, weighting by the inverse variance when combining across propensity score subclasses results in more efficient estimates that ultimately change inference. Copyright © 2016 John Wiley & Sons, Ltd.

SiM Optimization & Learning Theory · 发表于 2016-07-18

Net reclassification index at event rate: properties and relationships

Michael J. Pencina, Ewout W. Steyerberg, Ralph B. D'Agostino

摘要

The net reclassification improvement (NRI) is an attractively simple summary measure quantifying improvement in performance because of addition of new risk marker(s) to a prediction model. Originally proposed for settings with well‐established classification thresholds, it quickly extended into applications with no thresholds in common use. Here we aim to explore properties of the NRI at event rate. We express this NRI as a difference in performance measures for the new versus old model and show that the quantity underlying this difference is related to several global as well as decision analytic measures of model performance. It maximizes the relative utility (standardized net benefit) across all classification thresholds and can be viewed as the Kolmogorov–Smirnov distance between the distributions of risk among events and non‐events. It can be expressed as a special case of the continuous NRI, measuring reclassification from the ‘null’ model with no predictors. It is also a criterion based on the value of information and quantifies the reduction in expected regret for a given regret function, casting the NRI at event rate as a measure of incremental reduction in expected regret. More generally, we find it informative to present plots of standardized net benefit/relative utility for the new versus old model across the domain of classification thresholds. Then, these plots can be summarized with their maximum values, and the increment in model performance can be described by the NRI at event rate. We provide theoretical examples and a clinical application on the evaluation of prognostic biomarkers for atrial fibrillation. Copyright © 2016 John Wiley & Sons, Ltd.

Biometrika Other · 发表于 2016-07-18

Accurate directional inference for vector parameters

D. A. S. Fraser, N. Reid, N. Sartori

摘要

We consider statistical inference for a vector-valued parameter of interest in a regular asymptotic model with a finite-dimensional nuisance parameter. We use highly accurate likelihood theory to derive a directional test, in which the |$p$|-value is obtained by one-dimensional numerical integration. This extends the results of Davison et al. (2014) for linear exponential families to nonlinear parameters of interest and to more general models. Examples and simulations provide comparisons with the likelihood ratio test and adjusted versions of the likelihood ratio test. The directional approach gives extremely accurate inference, even in high-dimensional settings where the likelihood ratio versions can fail catastrophically. *(abstract via OpenAlex)*

SiM Bayesian Methods Missing Data & Measurement Error · 发表于 2016-07-18

A note on posterior predictive checks to assess model fit for incomplete data

Dandan Xu, Arkendu Chatterjee, Michael Daniels

摘要

We examine two posterior predictive distribution based approaches to assess model fit for incomplete longitudinal data. The first approach assesses fit based on replicated complete data as advocated in Gelman et al . (2005). The second approach assesses fit based on replicated observed data. Differences between the two approaches are discussed and an analytic example is presented for illustration and understanding. Both checks are applied to data from a longitudinal clinical trial. The proposed checks can easily be implemented in standard software like (Win)BUGS/JAGS/Stan. Copyright © 2016 John Wiley & Sons, Ltd.

SiM Longitudinal Data · 发表于 2016-07-14

Multivariate analysis of longitudinal rates of change

Matthew Bryan, Patrick J. Heagerty

摘要

Longitudinal data allow direct comparison of the change in patient outcomes associated with treatment or exposure. Frequently, several longitudinal measures are collected that either reflect a common underlying health status, or characterize processes that are influenced in a similar way by covariates such as exposure or demographic characteristics. Statistical methods that can combine multivariate response variables into common measures of covariate effects have been proposed in the literature. Current methods for characterizing the relationship between covariates and the rate of change in multivariate outcomes are limited to select models. For example, ‘accelerated time’ methods have been developed which assume that covariates rescale time in longitudinal models for disease progression. In this manuscript, we detail an alternative multivariate model formulation that directly structures longitudinal rates of change and that permits a common covariate effect across multiple outcomes. We detail maximum likelihood estimation for a multivariate longitudinal mixed model. We show via asymptotic calculations the potential gain in power that may be achieved with a common analysis of multiple outcomes. We apply the proposed methods to the analysis of a trivariate outcome for infant growth and compare rates of change for HIV infected and uninfected infants. Copyright © 2016 John Wiley & Sons, Ltd.

SiM Causal Inference Nonparametric & Semiparametric · 发表于 2016-07-14

An alternative empirical likelihood method in missing response problems and causal inference

Kaili Ren, Christopher A. Drummond, Pamela S. Brewster, Steven T. Haller, Jiang Tian, Christopher J. Cooper, Biao Zhang

摘要

Missing responses are common problems in medical, social, and economic studies. When responses are missing at random, a complete case data analysis may result in biases. A popular debias method is inverse probability weighting proposed by Horvitz and Thompson. To improve efficiency, Robins et al. proposed an augmented inverse probability weighting method. The augmented inverse probability weighting estimator has a double‐robustness property and achieves the semiparametric efficiency lower bound when the regression model and propensity score model are both correctly specified. In this paper, we introduce an empirical likelihood‐based estimator as an alternative to Qin and Zhang (2007). Our proposed estimator is also doubly robust and locally efficient. Simulation results show that the proposed estimator has better performance when the propensity score is correctly modeled. Moreover, the proposed method can be applied in the estimation of average treatment effect in observational causal inferences. Finally, we apply our method to an observational study of smoking, using data from the Cardiovascular Outcomes in Renal Atherosclerotic Lesions clinical trial. Copyright © 2016 John Wiley & Sons, Ltd.

SiM Diagnostics & Prediction Clinical Trials Bayesian Methods · 发表于 2016-07-14

An adaptive design for updating the threshold value of a continuous biomarker

Amy V. Spencer, Chris Harbron, Adrian Mander, James Wason, Ian Peers

摘要

Potential predictive biomarkers are often measured on a continuous scale, but in practice, a threshold value to divide the patient population into biomarker ‘positive’ and ‘negative’ is desirable. Early phase clinical trials are increasingly using biomarkers for patient selection, but at this stage, it is likely that little will be known about the relationship between the biomarker and the treatment outcome. We describe a single‐arm trial design with adaptive enrichment, which can increase power to demonstrate efficacy within a patient subpopulation, the parameters of which are also estimated. Our design enables us to learn about the biomarker and optimally adjust the threshold during the study, using a combination of generalised linear modelling and Bayesian prediction. At the final analysis, a binomial exact test is carried out, allowing the hypothesis that ‘no population subset exists in which the novel treatment has a desirable response rate’ to be tested. Through extensive simulations, we are able to show increased power over fixed threshold methods in many situations without increasing the type‐I error rate. We also show that estimates of the threshold, which defines the population subset, are unbiased and often more precise than those from fixed threshold studies. We provide an example of the method applied (retrospectively) to publically available data from a study of the use of tamoxifen after mastectomy by the German Breast Study Group, where progesterone receptor is the biomarker of interest. © 2016 The Authors. Statistics in Medicine published by John Wiley & Sons Ltd.

SiM Longitudinal Data Survival Analysis · 发表于 2016-07-13

Estimating time to event characteristics via longitudinal threshold regression models ‐ an application to cervical dilation progression

Caroline M. Mulatya, Alexander C. McLain, Bo Cai, James W. Hardin, Paul S. Albert

摘要

In longitudinal studies, it is sometimes of interest to estimate the distribution of the time a longitudinal process takes to traverse from one threshold to another. For example, the distribution of the time it takes a woman's cervical dilation to progress from 3 to 4 cm can aid the decision‐making of obstetricians as to whether a stalled labor should be allowed to proceed or stopped in favor of other options. Often researchers treat this type of data structure as interval censored and employ traditional survival analysis methods. However, the traditional interval censoring approaches are inefficient in that they do not use all of the available data. In this paper, we propose utilizing a longitudinal threshold model to estimate the distribution of the elapsed time between two thresholds of the longitudinal process from repeated measurements. We extend this modeling framework to be used with multiple thresholds. A Wiener process under the first hitting time framework is used to represent survival distribution. We demonstrate our model through simulation studies and an analysis of data from the Consortium on Safe Labor study. Published 2016. This article is a U.S. Government work and is in the public domain in the USA.

SiM Causal Inference · 发表于 2016-07-13

Estimating causal contrasts involving intermediate variables in the presence of selection bias

Linda Valeri, Brent A. Coull

摘要

An important goal across the biomedical and social sciences is the quantification of the role of intermediate factors in explaining how an exposure exerts an effect on an outcome. Selection bias has the potential to severely undermine the validity of inferences on direct and indirect causal effects in observational as well as in randomized studies. The phenomenon of selection may arise through several mechanisms, and we here focus on instances of missing data. We study the sign and magnitude of selection bias in the estimates of direct and indirect effects when data on any of the factors involved in the analysis is either missing at random or not missing at random. Under some simplifying assumptions, the bias formulae can lead to nonparametric sensitivity analyses. These sensitivity analyses can be applied to causal effects on the risk difference and risk-ratio scales irrespectively of the estimation approach employed. To incorporate parametric assumptions, we also develop a sensitivity analysis for selection bias in mediation analysis in the spirit of the expectation-maximization algorithm. The approaches are applied to data from a health disparities study investigating the role of stage at diagnosis on racial disparities in colorectal cancer survival. Copyright © 2016 John Wiley & Sons, Ltd. *(abstract via PubMed)*

SMMR Testing & Uncertainty · 发表于 2016-07-11

Zero-inflated Poisson model based likelihood ratio test for drug safety signal detection

Lan Huang, Dan Zheng, Jyoti Zalkikar, Ram Tiwari

摘要

In recent decades, numerous methods have been developed for data mining of large drug safety databases, such as Food and Drug Administration’s (FDA’s) Adverse Event Reporting System, where data matrices are formed by drugs such as columns and adverse events as rows. Often, a large number of cells in these data matrices have zero cell counts and some of them are “true zeros” indicating that the drug-adverse event pairs cannot occur, and these zero counts are distinguished from the other zero counts that are modeled zero counts and simply indicate that the drug-adverse event pairs have not occurred yet or have not been reported yet. In this paper, a zero-inflated Poisson model based likelihood ratio test method is proposed to identify drug-adverse event pairs that have disproportionately high reporting rates, which are also called signals. The maximum likelihood estimates of the model parameters of zero-inflated Poisson model based likelihood ratio test are obtained using the expectation and maximization algorithm. The zero-inflated Poisson model based likelihood ratio test is also modified to handle the stratified analyses for binary and categorical covariates (e.g. gender and age) in the data. The proposed zero-inflated Poisson model based likelihood ratio test method is shown to asymptotically control the type I error and false discovery rate, and its finite sample performance for signal detection is evaluated through a simulation study. The simulation results show that the zero-inflated Poisson model based likelihood ratio test method performs similar to Poisson model based likelihood ratio test method when the estimated percentage of true zeros in the database is small. Both the zero-inflated Poisson model based likelihood ratio test and likelihood ratio test methods are applied to six selected drugs, from the 2006 to 2011 Adverse Event Reporting System database, with varying percentages of observed zero-count cells.

SMMR High-Dimensional Nonparametric & Semiparametric Bayesian Methods · 发表于 2016-07-11

Variable selection in semi-parametric models

Hongmei Zhang, Arnab Maity, Hasan Arshad, John Holloway, Wilfried Karmaus

摘要

We propose Bayesian variable selection methods in semi-parametric models in the framework of partially linear Gaussian and problit regressions. Reproducing kernels are utilized to evaluate possibly non-linear joint effect of a set of variables. Indicator variables are introduced into the reproducing kernels for the inclusion or exclusion of a variable. Different scenarios based on posterior probabilities of including a variable are proposed to select important variables. Simulations are used to demonstrate and evaluate the methods. It was found that the proposed methods can efficiently select the correct variables regardless of the feature of the effects, linear or non-linear in an unknown form. The proposed methods are applied to two real data sets to identify cytosine phosphate guanine methylation sites associated with maternal smoking and cytosine phosphate guanine sites associated with cotinine levels with creatinine levels adjusted. The selected methylation sites have the potential to advance our understanding of the underlying mechanism for the impact of smoking exposure on health outcomes, and consequently benefit medical research in disease intervention.

第 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 页